Continuity Biosciences
Biofabrication platform for combination products using 3D microdispensing technology, founded by experts in translational medicine
- CEO / Founder
- Ramakrishna Venugopalan
- Team Size
- 1-10 employees
- Stage
- Active
- Total Funding
- $9.42M
- Latest Round
- Venture Round
- Key Investors
- Boston Micro Fabrication
Technology & Products
Key Products
["Dissolvable microneedle patches"]
Technological Advantage
Strategic partnership with Boston Micro Fabrication, providing access to micro-precision printing technology.
Differentiation
Value Proposition
Enabling precise, potentially painless delivery of therapeutics and cosmetics via advanced dissolvable microneedles manufactured with high-resolution 3D printing.
How They Differentiate
Focus on ultra-high resolution 3D printing through a strategic collaboration with Boston Micro Fabrication, allowing for unique geometries not attainable with conventional manufacturing.
Market & Competition
Target Customers
Pharmaceutical and cosmetic companies
Industry Verticals
["Pharmaceuticals","Cosmetics"]
Competitors
Vaxxas; Raphas; Kindeva Drug Delivery
Growth & Milestones
Major Milestones
["Announced strategic investment and collaboration with Boston Micro Fabrication (May 2024)"]
Notable Customers
Breakthrough T1D; Houston Methodist Hospital; Miami School of Medicine